S. Ausim Azizi, MD, PhD, Matthew T. Moore Chair and Professor of Investigative Neurology, Professor of Neurology, and Professor in the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University, spoke with KYW Newsradio about cluster headaches and the U.S. Food and Drug Administration’s recent approval of the medication Emgality for their treatment.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH